@article{6ae7ab5f72af4036ae301fe99d5d3e3e,
title = "Gaps in the diagnosis and management of iron overload in sickle cell disease: a {\textquoteleft}real-world{\textquoteright} report from the GRNDaD registry",
keywords = "Sickle cell disease, chronic transfusion, iron chelation, liver iron concentration, serum ferritin",
author = "{the GRNDaD investigators} and Wilson, {Samuel R.} and Matthew Sears and Elizabeth Williams and Jesse Drapekin and Ishwarya Sivakumar and Susan Padrino and Desai, {Payal C.} and Ward Hager and Deepa Manwani and Clay, {Leila J.} and Field, {Joshua J.} and Julie Kanter and Cohen, {Alice J.} and {Saif Ur Rehman}, Sana and Sophie Lanzkron and Little, {Jane A.}",
note = "Funding Information: SRW receives salary support from NIH 5T32HL007149‐44. PCD is a consultant for GBT, Novartis, Pfizer and is on the advisory board for Forma. WH is on the scientific review board, advisory board and research study development groups for Novartis. JK is a consultant with Novartis. SL is a consultant for bluebird bio and Pfizer, received an honorarium and research funding from Novartis, and research funding from GBT, Imara and Shire. JAL receives salary support from NHLBI (CureSci award) and research support from bluebird bio. The other authors have no other relevant conflict of interest to disclose. ",
year = "2021",
month = dec,
doi = "10.1111/bjh.17762",
language = "English",
volume = "195",
pages = "e157--e160",
journal = "British Journal of Haematology",
issn = "0007-1048",
number = "5",
}